PerpEquities

Equity

Arrowhead Pharmaceuticals, Inc. (ARWR) perpetual futures

ARWR perpetual futures on 1 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade ARWRUSDT.

Arrowhead Pharmaceuticals, Inc. tracked across crypto venues with normalized contract specifications.

$67.27-6.1%NASDAQ closed
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

Collecting venue price data...
venue perp mark · MEXC (ARWR/USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

1/1 live markets
Venues
1
Live markets
1/1
24h volume
$72.3K
Open interest
$85.6K
Best liquidity
$0
MEXC
Tightest spread
+1,217.9 bps
MEXC
Highest volume
$72.3K
MEXC
Settlement mix
USDT · 1/1
Perp/spot vol.
0.00x
Spot volume $171.8M
OI / float
0.00%
Float $8.3B
Spot performance
1D-6.82%
5D-1.28%
1M-23.13%
6M+18.16%
YTD+0.86%
1Y+106.03%

Venue matrix

1 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
MEXCTradeARWR/USDTTrading$67.27+15.8% APR
+0.014% every 8h
+1,217.9 bps$0$72.3K$85.6KUSDT20x

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

No sufficient depth · 0 of 1 venues absorb $10k

No fresh book data: MEXC

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

ARWR

Tightest spread

ARWR

Highest volume

ARWR

Funding history

Stored venue snapshots by market

Company data

Company fundamentals

Updated 2h ago
Market cap
$9.5B
Updated 2h ago
Revenue
$669.5M
Trailing 12 months
Revenue growth
-44%
Next fiscal year
Profit margin
-47.8%
P/E
-30.2
Peer P/E 4.9
Free cash flow
-$75.1M
Trailing 12 months
More metrics
Net income
-$320M
Trailing 12 months
P/S
14.2
Peer P/E
4.9
Similar listed perps
Revenue estimate
$461.1M
Next fiscal year
Earnings
2026-11-24
Revenue est. $59.4M · Updated 2h ago
Dividend
-

Fundamental detail

Annual + quarterly
Latest revenue$829.4M
Net margin-0.2%
Free cash flow$156.9M
Net debt$139.7M
2020$88M
2021$138.3M
2022$243.2M
2023$240.7M
2024$3.6M
2025$829.4M
PeriodRevenueGrowthNet incomeFCF
2020$88M-48%-$84.6M-$107.8M
2021$138.3M+57%-$140.8M$147.7M
2022$243.2M+76%-$176.1M-$188.9M
2023$240.7M-1%-$205.3M-$330.6M
2024$3.6M-99%-$599.5M-$604.3M
2025$829.4M+23,258%-$1.6M$156.9M
PeriodGross marginOperating marginNet marginROEROA
20200.0%-105.9%-96.1%-18.3%-16.2%
2021+100.0%-107.8%-101.9%-34.5%-19.8%
2022+95.7%-73.4%-72.4%-44.2%-25.4%
2023+94.8%-85.2%-85.3%-75.7%-26.8%
2024-423.7%-16,927.1%-16,882.4%-323.3%-52.6%
2025+100.0%+11.9%-0.2%-0.3%-0.1%
PeriodCashDebtNet debtCurrent ratio
2020$143.6M$21.1M-$122.4M7.92
2021$184.4M$25.5M-$158.9M2.62
2022$108M$81.6M-$26.4M2.92
2023$110.9M$383.5M$272.6M3.98
2024$102.7M$851.9M$749.2M6.74
2025$226.5M$366.3M$139.7M4.86
PeriodMarket capEnterprise valueP/SP/E
2020$4.3B$4.2B49.3-51.3
2021$6.5B$6.3B46.8-45.9
2022$3.5B$3.5B14.3-19.8
2023$2.9B$3.1B11.9-14.0
2024$2.3B$3.1B653.4-3.9
2025$4.6B$4.8B5.6-2,827.0
Q4 2024$0
Q1 2025$2.5M
Q2 2025$542.7M
Q3 2025$27.8M
Q4 2025$256.5M
Q1 2026$264M
Q2 2026$73.7M
Q3 2026$75.3M
PeriodRevenueGrowthNet incomeFCF
Q4 2024$0-100%-$170.5M-$161.5M
Q1 2025$2.5M-30%-$173.1M-$153.8M
Q2 2025$542.7M-$370.4M$454.8M
Q3 2025$27.8M--$175.2M-$157.1M
Q4 2025$256.5M--$23.8M$13M
Q1 2026$264M+10,461%$30.8M$11.3M
Q2 2026$73.7M-86%-$132.7M$81.9M
Q3 2026$75.3M+171%-$194.3M-$181.3M
PeriodGross marginOperating marginNet marginROEROA
Q4 20240.0%0.0%0.0%-92.0%-15.0%
Q1 2025+100.0%-6,456.5%-6,923.4%-329.1%-17.1%
Q2 2025+100.0%+70.2%+68.3%+54.2%+23.5%
Q3 2025+100.0%-596.2%-631.1%-33.6%-12.7%
Q4 2025+100.0%+17.2%-9.3%-5.1%-1.7%
Q1 2026+100.0%+15.5%+11.7%+5.4%+1.9%
Q2 2026+100.0%-191.6%-180.0%-21.6%-5.9%
Q3 2026+100.0%-226.0%-258.2%-41.7%-9.2%
PeriodCashDebtNet debtCurrent ratio
Q4 2024$102.7M$851.9M$749.2M6.74
Q1 2025$53.9M$872M$818.2M6.09
Q2 2025$185.7M$740.5M$554.8M5.15
Q3 2025$129.8M$713.3M$583.5M4.87
Q4 2025$226.5M$366.3M$139.7M4.86
Q1 2026$201.6M$312.8M$111.1M3.38
Q2 2026$188.5M$1.4B$1.2B6.23
Q3 2026$54.8M$864.1M$809.3M5.90
PeriodMarket capEnterprise valueP/SP/E
Q4 2024$2.4B$3.1B0.0-3.5
Q1 2025$2.3B$3.2B938.9-3.4
Q2 2025$1.7B$2.3B3.11.1
Q3 2025$2.2B$2.8B79.1-3.1
Q4 2025$4.7B$4.8B18.2-50.7
Q1 2026$9.3B$9.4B35.275.4
Q2 2026$8.9B$10.1B121.1-16.9
Q3 2026$11.7B$12.5B155.3-15.0

Refreshed 2h ago

Charts: revenue, profit, cash flow & valuation
Revenue$75.3MQ3 2026
$135.7M$271.4M$407M$542.7MQ4 2023: $16.1MQ1 2024: $3.6MQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $2.5MQ2 2025: $542.7MQ3 2025: $27.8MQ4 2025: $256.5MQ1 2026: $264MQ2 2026: $73.7MQ3 2026: $75.3MQ4 2023Q3 2026
Net income-$194.3MQ3 2026
-$53.1M$88.1M$229.3M$370.4MQ4 2023: -$109.7MQ1 2024: -$132.9MQ2 2024: -$125.3MQ3 2024: -$170.8MQ4 2024: -$170.5MQ1 2025: -$173.1MQ2 2025: $370.4MQ3 2025: -$175.2MQ4 2025: -$23.8MQ1 2026: $30.8MQ2 2026: -$132.7MQ3 2026: -$194.3MQ4 2023Q3 2026
EBITDA-$154.3MQ3 2026
-$23.7M$116.6M$257M$397.3MQ4 2023: -$99.9MQ1 2024: -$129.1MQ2 2024: -$115.2MQ3 2024: -$164.1MQ4 2024: -$153.1MQ1 2025: -$148.2MQ2 2025: $397.3MQ3 2025: -$148.5MQ4 2025: $64.2MQ1 2026: $57.2MQ2 2026: -$107.4MQ3 2026: -$154.3MQ4 2023Q3 2026
Free cash flow-$181.3MQ3 2026
-$26.2M$134.1M$294.4M$454.8MQ4 2023: -$89.2MQ1 2024: -$186.5MQ2 2024: -$126.5MQ3 2024: -$129.9MQ4 2024: -$161.5MQ1 2025: -$153.8MQ2 2025: $454.8MQ3 2025: -$157.1MQ4 2025: $13MQ1 2026: $11.3MQ2 2026: $81.9MQ3 2026: -$181.3MQ4 2023Q3 2026
EPS-$1.36Q3 2026
-$0.36$0.68$1.71$2.75Q4 2023: -$1.02Q1 2024: -$1.24Q2 2024: -$1.02Q3 2024: -$1.38Q4 2024: -$1.4Q1 2025: -$1.39Q2 2025: $2.75Q3 2025: -$1.26Q4 2025: -$0.17Q1 2026: $0.22Q2 2026: -$0.93Q3 2026: -$1.36Q4 2023Q3 2026
Cash / Debt$54.8MQ3 2026
$343.3M$686.6M$1B$1.4BQ4 2023 · Cash: $110.9MQ4 2023 · Debt: $383.5MQ1 2024 · Cash: $58.2MQ1 2024 · Debt: $392.3MQ2 2024 · Cash: $127.7MQ2 2024 · Debt: $399.9MQ3 2024 · Cash: $69.4MQ3 2024 · Debt: $454.1MQ4 2024 · Cash: $102.7MQ4 2024 · Debt: $851.9MQ1 2025 · Cash: $53.9MQ1 2025 · Debt: $872MQ2 2025 · Cash: $185.7MQ2 2025 · Debt: $740.5MQ3 2025 · Cash: $129.8MQ3 2025 · Debt: $713.3MQ4 2025 · Cash: $226.5MQ4 2025 · Debt: $366.3MQ1 2026 · Cash: $201.6MQ1 2026 · Debt: $312.8MQ2 2026 · Cash: $188.5MQ2 2026 · Debt: $1.4BQ3 2026 · Cash: $54.8MQ3 2026 · Debt: $864.1MQ4 2023Q3 2026
CashDebt
Profitability+100.0%Q3 2026
-5,167.6%-3,411.7%-1,655.8%+100.0%Q4 2023 · Gross margin: +76.0%Q1 2024 · Gross margin: -20.1%Q2 2024 · Gross margin: 0.0%Q3 2024 · Gross margin: 0.0%Q4 2024 · Gross margin: 0.0%Q1 2025 · Gross margin: +100.0%Q2 2025 · Gross margin: +100.0%Q3 2025 · Gross margin: +100.0%Q4 2025 · Gross margin: +100.0%Q1 2026 · Gross margin: +100.0%Q2 2026 · Gross margin: +100.0%Q3 2026 · Gross margin: +100.0%Q4 2023 · Operating margin: -673.0%Q1 2024 · Operating margin: -3,845.3%Q2 2024 · Operating margin: 0.0%Q3 2024 · Operating margin: 0.0%Q4 2024 · Operating margin: 0.0%Q1 2025 · Operating margin: -6,456.5%Q2 2025 · Operating margin: +70.2%Q3 2025 · Operating margin: -596.2%Q4 2025 · Operating margin: +17.2%Q1 2026 · Operating margin: +15.5%Q2 2026 · Operating margin: -191.6%Q3 2026 · Operating margin: -226.0%Q4 2023 · Net margin: -681.4%Q1 2024 · Net margin: -3,741.6%Q2 2024 · Net margin: 0.0%Q3 2024 · Net margin: 0.0%Q4 2024 · Net margin: 0.0%Q1 2025 · Net margin: -6,923.4%Q2 2025 · Net margin: +68.3%Q3 2025 · Net margin: -631.1%Q4 2025 · Net margin: -9.3%Q1 2026 · Net margin: +11.7%Q2 2026 · Net margin: -180.0%Q3 2026 · Net margin: -258.2%Q4 2023Q3 2026
Gross marginOperating marginNet margin
Revenue growth+171.0%Q3 2026
+2,540.3%+5,180.7%+7,821.0%+10,461.3%Q4 2024: -100.0%Q1 2025: -29.6%Q1 2026: +10,461.3%Q2 2026: -86.4%Q3 2026: +171.0%Q4 2023Q3 2026
Shares outstanding143.4MQ3 2026
35.8M71.7M107.5M143.4MQ4 2023: 107.3MQ1 2024: 107.4MQ2 2024: 123.3MQ3 2024: 124.2MQ4 2024: 122MQ1 2025: 124.8MQ2 2025: 134.5MQ3 2025: 139MQ4 2025: 135.7MQ1 2026: 140.7MQ2 2026: 142.4MQ3 2026: 143.4MQ4 2023Q3 2026
Valuation-15.0Q3 2026
196.7444.1691.5938.9Q4 2023 · P/E: -6.6Q1 2024 · P/E: -6.2Q2 2024 · P/E: -6.9Q3 2024 · P/E: -4.7Q4 2024 · P/E: -3.5Q1 2025 · P/E: -3.4Q2 2025 · P/E: 1.1Q3 2025 · P/E: -3.1Q4 2025 · P/E: -50.7Q1 2026 · P/E: 75.4Q2 2026 · P/E: -16.9Q3 2026 · P/E: -15.0Q4 2023 · P/S: 179.1Q1 2024 · P/S: 925.6Q2 2024 · P/S: 0.0Q3 2024 · P/S: 0.0Q4 2024 · P/S: 0.0Q1 2025 · P/S: 938.9Q2 2025 · P/S: 3.1Q3 2025 · P/S: 79.1Q4 2025 · P/S: 18.2Q1 2026 · P/S: 35.2Q2 2026 · P/S: 121.1Q3 2026 · P/S: 155.3Q4 2023Q3 2026
P/EP/S
Revenue$829.4M2025
$207.4M$414.7M$622.1M$829.4M2018: $16.1M2019: $168.8M2020: $88M2021: $138.3M2022: $243.2M2023: $240.7M2024: $3.6M2025: $829.4M20182025
Net income-$1.6M2025
-$432.6M-$265.8M-$98.9M$68M2018: -$54.5M2019: $68M2020: -$84.6M2021: -$140.8M2022: -$176.1M2023: -$205.3M2024: -$599.5M2025: -$1.6M20182025
EBITDA$164.8M2025
-$379.9M-$198.3M-$16.8M$164.8M2018: -$51.2M2019: $65.6M2020: -$87.2M2021: -$132.6M2022: -$162.3M2023: -$175.7M2024: -$561.5M2025: $164.8M20182025
Free cash flow$156.9M2025
-$413M-$221.6M-$30.3M$161M2018: -$48.6M2019: $161M2020: -$107.8M2021: $147.7M2022: -$188.9M2023: -$330.6M2024: -$604.3M2025: $156.9M20182025
EPS-$0.012025
-$3.58-$2.16-$0.73$0.692018: -$0.652019: $0.692020: -$0.842021: -$1.362022: -$1.672023: -$1.922024: -$52025: -$0.0120182025
Cash / Debt$226.5M2025
$213M$426M$638.9M$851.9M2018 · Cash: $30.1M2018 · Debt: $2.3M2019 · Cash: $221.8M2019 · Debt: $02020 · Cash: $143.6M2020 · Debt: $21.1M2021 · Cash: $184.4M2021 · Debt: $25.5M2022 · Cash: $108M2022 · Debt: $81.6M2023 · Cash: $110.9M2023 · Debt: $383.5M2024 · Cash: $102.7M2024 · Debt: $851.9M2025 · Cash: $226.5M2025 · Debt: $366.3M20182025
CashDebt
Profitability+100.0%2025
-12,670.3%-8,413.5%-4,156.8%+100.0%2018 · Gross margin: 0.0%2019 · Gross margin: 0.0%2020 · Gross margin: 0.0%2021 · Gross margin: +100.0%2022 · Gross margin: +95.7%2023 · Gross margin: +94.8%2024 · Gross margin: -423.7%2025 · Gross margin: +100.0%2018 · Operating margin: -346.5%2019 · Operating margin: +36.3%2020 · Operating margin: -105.9%2021 · Operating margin: -107.8%2022 · Operating margin: -73.4%2023 · Operating margin: -85.2%2024 · Operating margin: -16,927.1%2025 · Operating margin: +11.9%2018 · Net margin: -337.3%2019 · Net margin: +40.3%2020 · Net margin: -96.1%2021 · Net margin: -101.9%2022 · Net margin: -72.4%2023 · Net margin: -85.3%2024 · Net margin: -16,882.4%2025 · Net margin: -0.2%20182025
Gross marginOperating marginNet margin
Revenue growth+23,258.2%2025
+5,740.6%+11,579.8%+17,419.0%+23,258.2%2019: +945.7%2020: -47.9%2021: +57.2%2022: +75.9%2023: -1.0%2024: -98.5%2025: +23,258.2%20182025
Shares outstanding133.8M2025
33.4M66.9M100.3M133.8M2018: 83.6M2019: 98.6M2020: 100.7M2021: 103.7M2022: 105.4M2023: 106.8M2024: 119.8M2025: 133.8M20182025
Valuation-2,827.02025
-1,956.9-1,086.8-216.7653.42018 · P/E: -29.62019 · P/E: 39.12020 · P/E: -51.32021 · P/E: -45.92022 · P/E: -19.82023 · P/E: -14.02024 · P/E: -3.92025 · P/E: -2,827.02018 · P/S: 99.52019 · P/S: 15.72020 · P/S: 49.32021 · P/S: 46.82022 · P/S: 14.32023 · P/S: 11.92024 · P/S: 653.42025 · P/S: 5.620182025
P/EP/S

Next catalyst

Catalysts

Earnings
2026-11-24
Revenue est. $59.4M · Updated 2h ago

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 2026-3.55$461.1M-44%12
FY 2027-4.66$343M-59%12
FY 2028-2.57$752.7M-9%7
FY 2029-0.74$1.1B+38%2
FY 20304.41$2B+146%4
Q2 2026-1.28$44.2M-40%10

Company events

6
2026-11-24EarningsActual - / Estimate -1.59-
2026-08-04EarningsActual -1.36 / Estimate -1.28Miss
2026-05-07EarningsActual -0.93 / Estimate -1.09Beat
2026-02-05EarningsActual 0.22 / Estimate 0.6Miss
2025-11-25EarningsActual -0.18 / Estimate -0.11Miss
2025-08-07EarningsActual -1.26 / Estimate -0.94Miss

Peer comparison

Similar listed perps

Analyst track record

How the analysts covering ARWR have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings98271
Analysts1522
Buy / hold / sell85 / 13 / 0199 / 72 / 0
Upgrades / downgrades / initiations1 / 0 / 31 / 2 / 6
Price targets hit / missed17 / 70 (20%)145 / 92 (61%)
Avg. return after a rating (TipRanks)-16.7%+40.8%
Best / worst call+92.7% / -46.5%+462.1% / -46.5%

After buy calls on this stock: not enough measured cases yet

Latest ratings

DateAnalystCallTarget
Sep 21, 2026Patrick TrucchioH.C. WainwrightBuyMaintained$120
Sep 16, 2026Eric JosephCitiBuyReiterated
Sep 15, 2026Brian ChengJ.P. MorganBuyReiterated
Sep 9, 2026Eric JosephCitiBuyInitiated$108
Aug 31, 2026Brian ChengJ.P. MorganBuyMaintained

TipRanks data via FMP · computed Sep 23, 2026 · 98 ratings

Frequently asked questions

Where can I trade ARWR perpetual futures?

Arrowhead Pharmaceuticals, Inc. (ARWR) perpetual futures trade on 1 crypto venues, including MEXC. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade ARWR around the clock?

Yes. Unlike the underlying stock, ARWR perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on ARWR perpetuals?

Right now the ARWR perp funding rate is +15.8% annualized (venue median), ranging from +15.8% to +15.8% across 1 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the ARWR perp price compare to the Arrowhead Pharmaceuticals, Inc. stock?

The venue-median ARWR perp mark is $67.3 versus a reference stock price of $67.3, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a ARWR perpetual future?

A ARWR perpetual is a derivative that tracks the price of Arrowhead Pharmaceuticals, Inc. with no expiry date. It lets you take long or short exposure to Arrowhead Pharmaceuticals, Inc. on crypto venues, around the clock.

What is ARWRUSDT perpetual?

ARWRUSDT is the symbol most crypto exchanges use for the Arrowhead Pharmaceuticals, Inc. perpetual settled in USDT (Tether). It tracks the ARWR share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

ARWR perpetuals · perpequities.comARWR perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/arwr-perp"><img src="https://perpequities.com/badge/arwr-perp.svg" width="240" height="64" alt="ARWR perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of ARWR perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for ARWR — one email every Sunday.

Watchlist and alerts

Price and funding alerts for ARWR, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X